Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 1
Submit an article Journal homepage
3,778
Views
15
CrossRef citations to date
0
Altmetric
Research Paper

Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old

Desirée Van OorschotGSK, Wavre, BelgiumCorrespondence[email protected]
View further author information
,
Anastassia AnastassopoulouGSK Munich, GermanyView further author information
,
Barbara Poulsen NautrupEAH Consulting, Aachen, GermanyView further author information
,
Lijoy VargheseGSK, Singapore, SingaporeView further author information
,
Alfred von KrempelhuberGSK Munich, GermanyView further author information
,
Mohamed NeineFreelance, on behlaf of GSK, Wavre, BelgiumView further author information
,
Stéphane LorencFreelance, on behlaf of GSK, Wavre, BelgiumView further author information
&
Desmond CurranGSK, Wavre, BelgiumView further author information
 show all
Pages 34-44 | Received 19 Apr 2018, Accepted 28 Jul 2018, Published online: 06 Sep 2018

Related Research Data

Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults
Source: (:unav)

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.